As of 2025-09-05, the Fair Value of Iteos Therapeutics Inc (ITOS) is -94.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.15 USD, the upside of Iteos Therapeutics Inc is -1,034.85%.
With the market price of 10.15 USD and our fair value calculation, Iteos Therapeutics Inc (ITOS) is not a good investment. Investing in ITOS stocks now will result in a potential loss of 1,034.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -38.00 | 214.50 | 96.70 | -112.64 | -134.41 | 5.23 |
| YoY growth | -68.89% | 664.47% | -54.92% | -216.49% | -19.33% | 60.97% |
| Market Cap (mil) | 448.73 |
| P/E | |
| Forward P/E |
| EPS | -3.80 |
| Avg earnings growth rate | 60.97% |
| TTM earnings | -167.80 |